相似文献
1
Key Takeaways From the U.S. CDC's 2019 Antibiotic Resistance Threats Report for Frontline Providers.
Crit Care Med. 2020 Jul;48(7):939-945. doi: 10.1097/CCM.0000000000004371.
2
[Antibacterial drug resistance in Latin America: consequences for infectious disease control].
Rev Panam Salud Publica. 2011 Dec;30(6):519-28.
3
Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005.
Emerg Infect Dis. 2008 Nov;14(11):1756-8. doi: 10.3201/eid1411.080337.
4
Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: a case-based review.
J Hosp Med. 2009 Jul;4(6):E8-15. doi: 10.1002/jhm.505.
5
6
The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University Hospital Center in Marrakesh-Morocco.
J Infect Public Health. 2020 Apr;13(4):637-643. doi: 10.1016/j.jiph.2019.08.012. Epub 2019 Sep 16.
7
[Use of antibioticograms for individual programs of antibacterial therapy].
Antibiot Med Biotekhnol. 1985 Mar;30(3):212-21.
8
[Pefloxacin: clinical experience].
Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):596-9.
9
Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal.
BMC Infect Dis. 2017 Jul 11;17(1):483. doi: 10.1186/s12879-017-2584-5.
10
[Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhonghua Shao Shang Za Zhi. 2018 Nov 20;34(11):802-808. doi: 10.3760/cma.j.issn.1009-2587.2018.11.016.
引用本文的文献
1
Evaluation of current practice of antimicrobial use and clinical outcome in the management of pneumonia among pediatric patients admitted to Jimma Medical Center, Southwest Ethiopia: a prospective observational study.
Ann Med Surg (Lond). 2025 Aug 5;87(9):5470-5481. doi: 10.1097/MS9.0000000000003690. eCollection 2025 Sep.
2
Characterization and therapeutic evaluation of the lytic bacteriophage ENP2309 against vancomycin-resistant Enterococcus faecalis infections in a mice model.
Virol J. 2025 Aug 28;22(1):292. doi: 10.1186/s12985-025-02917-1.
3
Effect of Multi-Species Probiotic Supplementation on Fecal Microbiota in Pre-Weaned Holstein Dairy Calves in California.
Microorganisms. 2025 Aug 2;13(8):1810. doi: 10.3390/microorganisms13081810.
4
Investigation of Bacterial Infections and Antibiotic Resistance Patterns Among Clinical Isolates in the Center of Iran.
Int J Microbiol. 2025 Aug 9;2025:4694690. doi: 10.1155/ijm/4694690. eCollection 2025.
5
Coniontins, lipopetaibiotics active against Candida auris identified from a microbial natural product fractionation library.
Nat Commun. 2025 Aug 8;16(1):7337. doi: 10.1038/s41467-025-62630-z.
6
Identifying drivers of β-lactam/β-lactamase inhibitor resistance emergence and spread before their clinical deployment.
medRxiv. 2025 Jul 30:2025.07.29.25331838. doi: 10.1101/2025.07.29.25331838.
7
The genomic configurations driving antimicrobial resistance and virulence in colistin resistant Pseudomonas aeruginosa from an Egyptian Tertiary Oncology Hospital.
PLOS Glob Public Health. 2025 Aug 5;5(8):e0004976. doi: 10.1371/journal.pgph.0004976. eCollection 2025.
8
Antibiotic Therapy Duration for Multidrug-Resistant Gram-Negative Bacterial Infections: An Evidence-Based Review.
Int J Mol Sci. 2025 Jul 18;26(14):6905. doi: 10.3390/ijms26146905.
9
Phenotypic Impact and Multivariable Assessment of Antifungal Susceptibility in Survival Using a Model.
J Fungi (Basel). 2025 May 24;11(6):406. doi: 10.3390/jof11060406.
10
β-lactam antibiotics vs vancomycin in treating methicillin-sensitive staphylococcus aureus bloodstream infections: a meta-analysis of clinical outcomes.
Eur J Clin Microbiol Infect Dis. 2025 May 30. doi: 10.1007/s10096-025-05164-y.
本文引用的文献
1
Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use.
JAMA Netw Open. 2020 Apr 1;3(4):e202899. doi: 10.1001/jamanetworkopen.2020.2899.
2
Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals.
Clin Infect Dis. 2021 Feb 16;72(4):611-621. doi: 10.1093/cid/ciaa061.
3
Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data.
Clin Infect Dis. 2020 Dec 3;71(9):e487-e496. doi: 10.1093/cid/ciaa084.
4
Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections.
Open Forum Infect Dis. 2019 Dec 12;6(12):ofz505. doi: 10.1093/ofid/ofz505. eCollection 2019 Dec.
5
External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals.
Open Forum Infect Dis. 2019 Feb 28;6(4):ofz110. doi: 10.1093/ofid/ofz110. eCollection 2019 Apr.
6
Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.
MMWR Morb Mortal Wkly Rep. 2019 Mar 8;68(9):214-219. doi: 10.15585/mmwr.mm6809e1.
7
Vital Signs: Trends in Staphylococcus aureus Infections in Veterans Affairs Medical Centers - United States, 2005-2017.
MMWR Morb Mortal Wkly Rep. 2019 Mar 8;68(9):220-224. doi: 10.15585/mmwr.mm6809e2.
8
Attributable mortality from extensively drug-resistant gram-negative infections using propensity-matched tracer antibiotic algorithms.
Am J Infect Control. 2019 Sep;47(9):1040-1047. doi: 10.1016/j.ajic.2019.01.010. Epub 2019 Feb 27.
9
Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016.
JAMA Intern Med. 2019 Apr 1;179(4):479-488. doi: 10.1001/jamainternmed.2018.7269.
10
Infections Caused by Carbapenem-Resistant : An Update on Therapeutic Options.
Front Microbiol. 2019 Jan 30;10:80. doi: 10.3389/fmicb.2019.00080. eCollection 2019.
Zotero 插件